Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial. [electronic resource]
Producer: 20130809Description: 195-203 p. digitalISSN:- 1473-4877
- Aged
- Aged, 80 and over
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Calcium -- administration & dosage
- Dietary Supplements
- Diphosphonates -- therapeutic use
- Female
- Follow-Up Studies
- Fractures, Bone -- prevention & control
- Hip -- physiology
- Humans
- Male
- Osteoporosis -- drug therapy
- Placebos
- Risk
- Spinal Fractures -- prevention & control
- Spinal Injuries
- Spine -- physiology
- Teriparatide -- administration & dosage
- Vitamin D -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.